Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Serena Marchetti

1PUBLICATIONS

17CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Oct 01, 2025

Checkpoint Blockade Combinations in Tumor Mutational Burden/Load-High Tumors: Insights from the Atezolizumab + Bevacizumab and Nivolumab + Ipilimumab Cohorts in the Drug Rediscovery Protocol.

Karlijn Verkerk, Soemeya F Haj Mohammad, Laurien J Zeverijn

Pageof 1

Frequent Collaborators

1 joint publications

Karlijn Verkerk

1 joint publications

Soemeya F Haj Mohammad

1 joint publications

Laurien J Zeverijn

1 joint publications

Birgit S Geurts

1 joint publications

Ilse A C Spiekman

1 joint publications

Florentine A J Verbeek

1 joint publications

Hans Timmer

1 joint publications

Maud A van Maren

1 joint publications

V van der Noort

1 joint publications

Miguel Parra Martinez

Frequent Collaborators

1 joint publications

Karlijn Verkerk

1 joint publications

Soemeya F Haj Mohammad

1 joint publications

Laurien J Zeverijn

1 joint publications

Birgit S Geurts

Top Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

See more related videos

Top Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

See more related videos